{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 456663702
| IUPAC_name = (8''R'',9''S'',10''R'',13''S'',14''S'')-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[''a'']phenanthren-3-one
| image = Levonorgestrel.svg
| width = 225px
| image2 = Dextronorgestrel.svg
| width2 = 225px
| caption = Top, '''levonorgestrel'''  (<small>CAS {{CAS|797-63-7}}</small>); <br />Bottom: '''dextronorgestrel''' (<small>CAS {{CAS|797-64-8}}</small>).

<!--Clinical data-->
| tradename = Ovral, others
| Drugs.com = {{drugs.com|CONS|norgestrel}}
| MedlinePlus = a602008
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = Rx-only
| legal_status =
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life = 5–14 hours
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 6533-00-2
| ATC_prefix = G03
| ATC_suffix = AA06
| ATC_supplemental = {{ATC|G03|FA10}} {{ATC|G03|FB01}} (only combinations with [[estrogen]]s)
| PubChem = 16051930
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = <!-- DB00367 this is levonorgestrel -->
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 10481953
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 3J8Q1747Z2
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00954
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = <!-- 1389 this is levonorgestrel -->
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 7630

<!--Chemical data-->
| C=21 | H=28 | O=2
| smiles = O=C\1CC[C@H]4C(=C/1)/CC[C@@H]3[C@@H]4CC[C@@]2(CC)[C@H]3CCC2(O)C#C
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21?/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = WWYNJERNGUHSAO-CULCCENASA-N
}}

'''Norgestrel''', sold under the brand name '''Ovral''' among others, is a [[progestin]] that is used in combination with an [[estrogen]] in [[hormonal contraceptive]]s.<ref name="Elks2014" /><ref name="IndexNominum2000" /> It has also been used as an [[emergency contraceptive]] in the [[Yuzpe regimen]].<ref>{{Cite journal |  authors = Yuzpe  AA, Smith RP & Rademaker AW | year = 1982 | title = A Multicenter Clinical Investigation Employing Ethinyl Estradiol Combined with dl-Norgestrel as Postcoital Contraceptive Agent | journal = Fertility and Sterility | volume = 37 | issue = 4 | pages = 508–513 | pmid = 7040117  | pmc =  | url =  | access-date =  }}</ref>

==Chemistry==
{{See also|List of steroidal progestogens|List of androgens/anabolic steroids|Levonorgestrel}}

Norgestrel, also known as '''''rac''-13-ethyl-17α-ethynyl-19-nortestosterone''' or as '''''rac''-13-ethyl-17α-ethynylestr-4-en-17β-ol-3-one''', is a [[synthetic compound|synthetic]] [[estrane]] [[steroid]] and a [[chemical derivative|derivative]] of [[testosterone]].<ref name="Elks2014" /><ref name="IndexNominum2000" /> It is a [[racemic mixture]] of [[stereoisomer]]s dextronorgestrel (the C13α isomer) and [[levonorgestrel]] (the C13β isomer), the former of which is inactive (making norgestrel exactly half as [[potency (pharmacology)|potent]] as levonorgestrel).<ref name="AlldredgeCorelli2012">{{cite book|author1=Brian K. Alldredge|author2=Robin L. Corelli|author3=Michael E. Ernst|title=Koda-Kimble and Young's Applied Therapeutics: The Clinical Use of Drugs|url=https://books.google.com/books?id=qcVpuHngXK0C&pg=PA1072|date=1 February 2012|publisher=Lippincott Williams & Wilkins|isbn=978-1-60913-713-7|pages=1072–}}</ref><ref name="LaverySanfilippo2012">{{cite book|author1=J.P. Lavery|author2=J.S. Sanfilippo|title=Pediatric and Adolescent Obstetrics and Gynecology|url=https://books.google.com/books?id=l9XTBwAAQBAJ&pg=PA248|date=6 December 2012|publisher=Springer Science & Business Media|isbn=978-1-4612-5064-7|pages=248–}}</ref> Norgestrel is more specifically a derivative of [[norethisterone]] (17α-ethynyl-19-nortestosterone) and is a member of the [[gonane]] (18-methylestrane) subgroup of the [[19-nortestosterone]] family of progestins.<ref name="OffermannsRosenthal2008">{{cite book|author1=Stefan Offermanns|author2=W. Rosenthal|title=Encyclopedia of Molecular Pharmacology|url=https://books.google.com/books?id=iwwo5gx8aX8C&pg=PA390|date=14 August 2008|publisher=Springer Science & Business Media|isbn=978-3-540-38916-3|pages=390–}}</ref>

==History==
Norgestrel was first introduced, as a contraceptive in combination with [[ethinylestradiol]] under the brand name '''Ovrette''' in the [[United States]], in 1968, and was subsequently marketed in many other countries.<ref name="Publishing2013" />

==Society and culture==

===Generic name===
''Norgestrel'' is the [[generic term|generic name]] of the drug and its {{abbrlink|INN|International Nonproprietary Name}}, {{abbrlink|USAN|United States Adopted Name}}, {{abbrlink|USP|United States Pharmacopeia}}, {{abbrlink|BAN|British Approved Name}}, {{abbrlink|DCF|Dénomination Commune Française}}, {{abbrlink|DCIT|Denominazione Comune Italiana}}, and {{abbrlink|JAN|Japanese Accepted Name}}.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA887|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=887–}}</ref><ref name="IndexNominum2000">{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&pg=PA751|year=2000|publisher=Taylor & Francis|isbn=978-3-88763-075-1|pages=751–}}</ref><ref name="Drugs.com">https://www.drugs.com/international/norgestrel.html</ref>

===Brand names===
Norgestrel has been marketed under a variety of brand names including Cyclacur, Cryselle, Cyclo-Progynova, Duoluton, Elinest, Eugynon, Microgynon, Lo/Ovral, Low-Ogestrel, Logynon, Microlut, Minicon, Nordette, Neogest, Ogestrel, '''Ovral''', Ovran, Ovranette, Ovrette, Planovar, Prempak, Progyluton, and Trinordiol among others.<ref name="Elks2014" /><ref name="IndexNominum2000" /><ref name="Drugs.com" /><ref name="Publishing2013">{{cite book|author=William Andrew Publishing|title=Pharmaceutical Manufacturing Encyclopedia, 3rd Edition|url=https://books.google.com/books?id=_J2ti4EkYpkC&pg=PA2935-IA56|date=22 October 2013|publisher=Elsevier|isbn=978-0-8155-1856-3|pages=2935–}}</ref>

==See also==
* [[Elsimar M. Coutinho]]
* [[Herchel Smith]]

==References==
{{Reflist|2}}

{{Progestogens and antiprogestogens}}
{{Androgen receptor modulators}}
{{Progesterone receptor modulators}}

[[Category:Alcohols]]
[[Category:Alkynes]]
[[Category:Androgens and anabolic steroids]]
[[Category:Estranes]]
[[Category:Ketones]]
[[Category:Progestogens]]